Our studies that aim to further understanding of mitochondrial and neurodegenerative diseases.
Status: Open to recruitment Background The Lily Foundation is the UK’s main patient organization for patients with mitochondrial disease. They are funding this study, which aims to get a genetic diagnosis for families who are thought to have mitochondrial disease but remain without a diagnosis after NHS testing. Objectives The study will look at existing […]
Read more »
The aim of this study is to understand how the disease changes over time in order to identify a clinical outcome measure that could be used for future trials.
The aim of this study is to understand how inherited optic neuropathies progress over time. We plan to achieve this by assessing a number of visual parameters and analysing how these may change over a three-year period.
The aim of this natural history study is to evaluate the rate of change for patients with ADOA, by completing eye and vision assessments,, assessing quality of life and exploring factors associated with disease progression.
The aim of this study is to better understand the natural history and progression of disease caused by mutations in MTRFR/C12orf65, by building a database of clinical data on these participants. This will help us to guide the design of innovative new clinical trials, with the long-term goal of developing treatments for patients.
This study is an international collaboration led by the University of Tübingen, Germany. The aim of this study is to better understand the clinical appearance and course of HSP, ataxia and related conditions (called a 'Natural History Study').
This study aims to identify the genetic causes of neuromuscular and other neurogenetic conditions, identify known and new disease genes and assess comparative genetic architecture of NMDs across four continents and to improve patient diagnosis and management of disorders, including delivery of personalized management plans
This study aims to measure the ‘age related penetrance’ of the genetic risk factors for dementia by comparing tests of brain function (including memory) to a person’s genetics and to establish the largest cohort of volunteers (~40,000) who can be recalled for future studies based on their detailed genetic and cognitive profile.
This study aims to provide patients with an explanation for their neurodegenerative disorder, to enable reliable genetic counselling and prenatal diagnosis, and to identify clinical biomarkers that could be used to monitor disease progression.
Nothing found
